ClinicalTrials.Veeva

Menu

Is Adipose Tissue a Reservoir for SARS-Cov2 Spread in Covid-19 Patients? (TA/SARS-Cov2)

C

Centre Hospitalier Universitaire de Nice

Status

Completed

Conditions

Covid-19 Patients

Treatments

Procedure: biopsies of subcutaneous adipose tissue

Study type

Interventional

Funder types

Other

Identifiers

NCT04427878
20-PP-15

Details and patient eligibility

About

Resident cells of human adipose tissue express ACE2 and DPP4, receptors for SARS-Cov2. The hypothesis is that the virus may enter and spread in fat depots.

Enrollment

5 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male or female ≥ 18 years old
  • Patients testing positive for Covid19
  • Patients affiliated to social security
  • Signing of free and informed consent

Exclusion criteria

  • Vulnerable persons (- minors,
  • adults under guardianship or curatorship,
  • pregnant women,
  • persons deprived of their liberty,
  • persons who do not master the French language)

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

5 participants in 1 patient group

patients with Covid-19
Experimental group
Treatment:
Procedure: biopsies of subcutaneous adipose tissue

Trial contacts and locations

1

Loading...

Central trial contact

Vanina OLIVERI, PM

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems